Content not available.
Please allow cookies by clicking Accept on the banner

Prof. Philippe Bouchard explains what are endocrine disruptors and what we can do to reduce their impact during the13th Congress of the European Society of Gynecology – Vienna 16/19 October 2019

ESG2019 – Facts and Figures

The last edition of the ESG congress, took place in Vienna from 16 to 19 October 2019, ending with an extremely positive balance. 1273 participants coming from 5 continents, 80 scientifc sessions and more than 180 international speakers. These are the most representive data of an event that confirmed: the opening to an international audience […]

Earn European CME while attending ESG 2019

The 13th Congress of the European Society of Gynecology has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

ESG 2019 – Deadline extended for Abstract Submission

We have received hundreds of abstracts and we would like to get more! The Scientific Committee is giving you more time to submit your abstract for Oral Presentation. The new deadlines for abstract submission are: Oral Presentation – Wednesday 31 July 2019 (extended) Posters – Monday 19 August 2019   Why should you present your […]

ESG 2019: Unauthorized website

We have recently been informed that our conference is being targeted by fraudulent and unauthorized website selling services (hotel booking and registrations) for the forthcoming ESG Congress in Vienna. The unauthorized website is This company is not authorized to act on behalf of the ESG. Therefore, we strongly advice all of our members and […]

This site uses cookies for functional and analytical purposes. Set cookie preference

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.